TMO · Price Movement Analysis

Why Is TMO Stock Down?

A forensic read of what's moving TMO — the story behind the price, not a buy or sell rating.

TMO price
 
Bullish narrative Monitoring
Narrative intelligence report Updated August 20, 2026 Refreshed daily
Stock Psycho verdict Monitoring

The short answer: there's no single catalyst — TMO is in a watch-and-wait state. Narrative energy is still elevated at 100%.

See the full TMO breakdown → Forensic narrative analysis · not financial advice

What's driving TMO's price action

The story driving TMO right now: Thermo Fisher Scientific has successfully completed the sale of its Microbiology Business to Astorg, indicating strategic portfolio optimization. High volatility-momentum readings (99) indicate significant narrative-driven price displacement.

Reality vs. Belief

How far TMO's narrative has drifted from its fundamentals.
REALITYBELIEF
Reality zone
21/100

TMO's story is largely grounded in its fundamentals — the price reflects what the company is actually doing.

Driving theme Earnings Season

TMO signal snapshot

The forensic readings behind the verdict.
Valuation gap
+13.8%
Above narrative fair value
Narrative energy
100%
Remaining fuel
Volatility-momentum
99
Price displacement
Narrative persistence
100
Unknown
Source credibility
84
Highly Credible
Coordination
5
Signal Lab — last 7 days
7D
Narrative Force Risk Pressure

TMO projected price & trade signal

Where the model says TMO is headed — and how a desk would position around it.
🔒 Members only
See TMO's projected price & full trade signal
Fair value, 30-day target, direction, entry/stop, and conviction are part of the full TMO analysis. Free to start.
Unlock full analysis → Already a member? Sign in

Is TMO overvalued?

TMO is trading 13.8% above estimated fair value — a modest premium that may or may not be justified by growth expectations.

Market Prism's verdict on TMO

Market Prism has TMO in Monitoring — signals are mixed and the narrative direction hasn't resolved one way or the other yet. Narrative energy remains elevated at 100%, so the story still has momentum.

What happens next for TMO

TMO is at a decision point. The signals to watch: narrative energy direction, fair-value convergence, and any shift in institutional positioning.

Frequently asked questions

Why is TMO stock down today?

The story driving TMO right now: Thermo Fisher Scientific has successfully completed the sale of its Microbiology Business to Astorg, indicating strategic portfolio optimization. High volatility-momentum readings (99) indicate significant narrative-driven price displacement.

Is TMO overvalued right now?

TMO is trading 13.8% above estimated fair value — a modest premium that may or may not be justified by growth expectations.

What is Market Prism's verdict on TMO?

Market Prism has TMO in Monitoring — signals are mixed and the narrative direction hasn't resolved one way or the other yet. Narrative energy remains elevated at 100%, so the story still has momentum.

Will TMO stock recover?

TMO is at a decision point. The signals to watch: narrative energy direction, fair-value convergence, and any shift in institutional positioning.

Stop guessing why TMO moves.

Stock Psycho reverse-engineers the story behind every price move — fair value, narrative energy, coordination, and the trade signal — across hundreds of tickers, refreshed daily.

Stock Psycho provides forensic narrative intelligence for informational purposes only. This is not financial advice. Projected values reflect narrative-implied modeling, not price predictions, and may be incomplete or unavailable for some tickers. See our methodology. All investment decisions should be made with independent verification and professional financial counsel.